C
Clemence Bonnet
Researcher at University of California, Los Angeles
Publications - 26
Citations - 160
Clemence Bonnet is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 4, co-authored 15 publications receiving 49 citations. Previous affiliations of Clemence Bonnet include Tehran University of Medical Sciences & University of Paris.
Papers
More filters
Journal ArticleDOI
Human limbal epithelial stem cell regulation, bioengineering and function.
Clemence Bonnet,Sheyla González,JoAnn S. Roberts,Sarah Y.T. Robertson,Maxime Ruiz,Jie Zheng,Sophie X. Deng +6 more
TL;DR: In this article, a review highlights the major advances in the identification of potential LSC biomarkers and components of the LSC niche, understanding of LSC regulation, methods and regulatory standards in bioengineering of LSPs, and diagnosis and staging of limbal stem cell deficiency (LSCD).
Journal ArticleDOI
Safety and efficacy of custom foldable silicone artificial iris implantation: prospective compassionate-use case series.
Clemence Bonnet,Kevin M. Miller +1 more
TL;DR: Custom artificial iris implantation was moderately risky but very effective at reducing light and glare sensitivity and improving ocular cosmesis.
Journal ArticleDOI
Corneal Blindness in Asia: A Systematic Review and Meta-Analysis to Identify Challenges and Opportunities.
Tu M Tran,Huong Duong,Huong Duong,Clemence Bonnet,Clemence Bonnet,Ashkan Kashanchi,Arjun Buckshey,Anthony J. Aldave +7 more
TL;DR: The prevalence of MSVI and blindness from corneal disease in Asia is approximately 0.4%, with a nearly 20-fold difference in the national prevalence across the region.
Journal ArticleDOI
Limbal stem cell diseases
TL;DR: The function of limbal stem/progenitor cells (LSCs) is critical to maintain corneal epithelial homeostasis Many external insults and intrinsic defects can be deleterious to LSCs and their niche micro-environment, resulting in Limbal stem cell dysfunction or deficiency as discussed by the authors.
Journal ArticleDOI
Long-term outcomes of Descemet membrane endothelial keratoplasty in eyes with prior glaucoma surgery
TL;DR: In eyes with prior glaucoma surgery, DMEK achieved good long-term visual outcomes, but experienced a higher rate of SGF than eyes without such comorbidity.